Clinical Trials
4 trialsNCT06708910 2025-09-24
AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI
Heinrich-Heine University, Duesseldorf
Recruiting
NCT06868758 2025-03-11
Predictive Value of Tumor Vascular Normalization Scoring in HER-2 Positive Breast Cancer
Chongqing General Hospital
Active not recruiting
NCT02673398 2023-06-18
Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer
City of Hope Medical Center
Phase 2 Completed
NCT03908749 2019-04-09
A Real-world Clinical Study of Pyrotinib Maleate Tablets in the Treatment of Breast Cancer Patients With Positive Her-2
Anhui Provincial Hospital
Unknown